BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 36465975)

  • 21. Ambrisentan response in connective tissue disease-associated pulmonary arterial hypertension (CTD-PAH) - A subgroup analysis of the ARIES-E clinical trial.
    Fischer A; Denton CP; Matucci-Cerinic M; Gillies H; Blair C; Tislow J; Nathan SD
    Respir Med; 2016 Aug; 117():254-63. PubMed ID: 27492539
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Simplified risk stratification for pulmonary arterial hypertension associated with connective tissue disease.
    Li X; Sun X; Huang Y; Wang Y; Yang X; Wang J; Zhang N; Gu L; Zhang M; Wang Q
    Clin Rheumatol; 2019 Dec; 38(12):3619-3626. PubMed ID: 31385084
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Multidisciplinary Approach in the Early Detection of Undiagnosed Connective Tissue Diseases in Patients With Interstitial Lung Disease: A Retrospective Cohort Study.
    Tirelli C; Morandi V; Valentini A; La Carrubba C; Dore R; Zanframundo G; Morbini P; Grignaschi S; Franconeri A; Oggionni T; Marasco E; De Stefano L; Kadija Z; Mariani F; Codullo V; Alpini C; Scirè C; Montecucco C; Meloni F; Cavagna L
    Front Med (Lausanne); 2020; 7():11. PubMed ID: 32133362
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dendritic Cell Subsets and Effector Function in Idiopathic and Connective Tissue Disease-Associated Pulmonary Arterial Hypertension.
    van Uden D; Boomars K; Kool M
    Front Immunol; 2019; 10():11. PubMed ID: 30723471
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Increased Levels of ICOS and ICOSL Are Associated to Pulmonary Arterial Hypertension in Patients Affected by Connective Tissue Diseases.
    Bellan M; Murano F; Ceruti F; Piccinino C; Tonello S; Minisini R; Giubertoni A; Sola D; Pedrazzoli R; Maglione V; Manfredi GF; Acquaviva A; Piffero R; Patti G; Pirisi M; Sainaghi PP
    Diagnostics (Basel); 2022 Mar; 12(3):. PubMed ID: 35328257
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The short-term role of corticosteroid therapy for pulmonary arterial hypertension associated with connective tissue diseases: report of five cases and a literature review.
    Kato M; Kataoka H; Odani T; Fujieda Y; Otomo K; Oku K; Horita T; Yasuda S; Atsumi T; Ohira H; Tsujino I; Nishimura M; Koike T
    Lupus; 2011 Oct; 20(10):1047-56. PubMed ID: 21676917
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pulmonary arterial hypertension complicating connective tissue diseases.
    Hassoun PM
    Semin Respir Crit Care Med; 2009 Aug; 30(4):429-39. PubMed ID: 19634082
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-Term Outcomes in Patients With Connective Tissue Disease-Associated Pulmonary Arterial Hypertension in the Modern Treatment Era: Meta-Analyses of Randomized, Controlled Trials and Observational Registries.
    Khanna D; Zhao C; Saggar R; Mathai SC; Chung L; Coghlan JG; Shah M; Hartney J; McLaughlin V
    Arthritis Rheumatol; 2021 May; 73(5):837-847. PubMed ID: 33538058
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Pulmonary arterial hypertension with connective tissue diseases].
    Fukaya S; Yoshida S
    Nihon Rinsho; 2008 Nov; 66(11):2200-4. PubMed ID: 19051743
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pulmonary capillary endothelial metabolic dysfunction: severity in pulmonary arterial hypertension related to connective tissue disease versus idiopathic pulmonary arterial hypertension.
    Langleben D; Orfanos SE; Giovinazzo M; Hirsch A; Baron M; Senécal JL; Armaganidis A; Catravas JD
    Arthritis Rheum; 2008 Apr; 58(4):1156-64. PubMed ID: 18383374
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An expert opinion of the Polish Cardiac Society Working Group on Pulmonary Circulation and the Polish Society for Rheumatology on the diagnosis and treatment of pulmonary hypertension in patients with connective tissue disease.
    Mularek-Kubzdela T; Ciurzyński M; Kowal Bielecka O; Kasprzak JD; Kopeć G; Mizia-Stec K; Mroczek E; Lewicka E; Skoczylas I; Grabka M; Furdal M; Florczyk M; Brzosko M; Batko B; Przepiera-Będzak H; Samborski W; Kucharz EJ
    Kardiol Pol; 2021; 79(7-8):917-929. PubMed ID: 34227677
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of Osteopontin as a Potential Biomarker of Pulmonary Arterial Hypertension in Patients with Systemic Sclerosis and Other Connective Tissue Diseases (CTDs).
    Bellan M; Piccinino C; Tonello S; Minisini R; Giubertoni A; Sola D; Pedrazzoli R; Gagliardi I; Zecca E; Calzaducca E; Mazzoleni F; Piffero R; Patti G; Pirisi M; Sainaghi PP
    Pharmaceuticals (Basel); 2021 Apr; 14(5):. PubMed ID: 33919476
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Red Cell Distribution Width and Platelet Count as Biomarkers of Pulmonary Arterial Hypertension in Patients with Connective Tissue Disorders.
    Bellan M; Giubertoni A; Piccinino C; Dimagli A; Grimoldi F; Sguazzotti M; Burlone ME; Smirne C; Sola D; Marino P; Pirisi M; Sainaghi PP
    Dis Markers; 2019; 2019():4981982. PubMed ID: 31275447
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Connective Tissue Disease-associated Interstitial Lung Diseases (CTD-ILD) - Report from OMERACT CTD-ILD Working Group.
    Khanna D; Mittoo S; Aggarwal R; Proudman SM; Dalbeth N; Matteson EL; Brown K; Flaherty K; Wells AU; Seibold JR; Strand V
    J Rheumatol; 2015 Nov; 42(11):2168-71. PubMed ID: 25729034
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Current and Emerging Drug Therapies for Connective Tissue Disease-Interstitial Lung Disease (CTD-ILD).
    Jee AS; Corte TJ
    Drugs; 2019 Sep; 79(14):1511-1528. PubMed ID: 31399860
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characteristics and Survival of Anti-U1 RNP Antibody-Positive Patients With Connective Tissue Disease-Associated Pulmonary Arterial Hypertension.
    Sobanski V; Giovannelli J; Lynch BM; Schreiber BE; Nihtyanova SI; Harvey J; Handler CE; Denton CP; Coghlan JG
    Arthritis Rheumatol; 2016 Feb; 68(2):484-93. PubMed ID: 26415038
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Value of intravascular ultrasound in the assessment of pulmonary vascular properties and mortality in patients with pulmonary artery hypertension associated with connective tissue diseases].
    Cai Z; Li J; Sun L; Yang C; Shen J; He B
    Zhonghua Xin Xue Guan Bing Za Zhi; 2015 Dec; 43(12):1061-7. PubMed ID: 26888841
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Exercise-based evaluations and interventions for pulmonary hypertension with connective tissue disorders.
    Babu AS; Morris NR; Arena R; Myers J
    Expert Rev Respir Med; 2018 Jul; 12(7):615-622. PubMed ID: 29798690
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Role of Pulmonary Function Test for Pulmonary Arterial Hypertension in Patients with Connective Tissue Disease.
    Xiong J; Li J; Huang Y; Yang F; Wu R
    Dis Markers; 2022; 2022():6066291. PubMed ID: 36212174
    [No Abstract]   [Full Text] [Related]  

  • 40. Hemodynamic Response to Treatment and Outcomes in Pulmonary Hypertension Associated With Interstitial Lung Disease Versus Pulmonary Arterial Hypertension in Systemic Sclerosis: Data From a Study Identifying Prognostic Factors in Pulmonary Hypertension Associated With Interstitial Lung Disease.
    Chauvelot L; Gamondes D; Berthiller J; Nieves A; Renard S; Catella-Chatron J; Ahmad K; Bertoletti L; Camara B; Gomez E; Launay D; Montani D; Mornex JF; Prévot G; Sanchez O; Schott AM; Subtil F; Traclet J; Turquier S; Zeghmar S; Habib G; Reynaud-Gaubert M; Humbert M; Cottin V
    Arthritis Rheumatol; 2021 Feb; 73(2):295-304. PubMed ID: 32892515
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.